Pharmaceutical Technology

NOVEMBER 21, 2022

Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 in 2022 to JPY9.498 trillion ($68.08 The post Warnings for Japanese pharmaceutical market may lead to more lenient price controls appeared first on Pharmaceutical Technology.

Pharmaceutical 52

Pharmaceutical Leads Marketing Manufacturing 52

Pharmaceutical Technology

JULY 28, 2022

After all, around a third of the world’s leading life sciences corporations have their headquarters in the country. The post What factors are driving life sciences FDI in 2022? appeared first on Pharmaceutical Technology. Industry clusters. Discover why global life sciences businesses are choosing this thriving region.

Transportation 52

Transportation Education Marketing Networking 52

Pharmaceutical Technology

MAY 9, 2023

With an increasing focus on ESG, Pharmaceutical companies are under pressure to incorporate sustainability with suppliers playing a crucial role in the process. GlobalData identified 349 environmental sustainability-related sentences in the company's filings - 46% of all sentences - and an increase of 600% in Q1 2023 compared with Q4 2022.

Pharmaceutical 52

Pharmaceutical Pharmaceutical manufacturing Government Manufacturing 52

European Pharmaceutical Review

SEPTEMBER 29, 2022

The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme. April 2022.

Management 97

Management Food and Drug Administration Manufacturing Pharmaceutical manufacturing 97

European Pharmaceutical Review

DECEMBER 21, 2022

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. Green Chemistry in the Synthesis of Pharmaceuticals.

Manufacturing 97

Manufacturing Pharmaceutical Healthcare Healthcare 97

Pharmaceutical Technology

MAY 9, 2023

With an increasing focus on ESG, Pharmaceutical companies are under pressure to incorporate corporate governance. Of the 50 leading companies in the pharmaceutical industry, GSK had the greatest increase in references for corporate governance in Q1 2023, compared with the previous quarter. Buy the report here.

Government 45

Government Pharmaceutical Pharmaceutical manufacturing Manufacturing 45

European Pharmaceutical Review

AUGUST 17, 2022

Despite this toll, AMR has often been called the ‘silent pandemic’: 4 “AMR is sadly silent because it has not been discussed like other pandemics – and of course has been in the shadow of the COVID-19 pandemic in recent years,” commented Melissa Gong Mitchell, Secretariat Lead of the AMR Industry Alliance. 2022 [cited 1 July 2022].

Manufacturing 98

Manufacturing Food and Drug Administration Management Pharmaceutical 98

PM360

OCTOBER 25, 2023

Combination Therapy in Oncology Combination therapies comprising two or more therapeutic agents have become a cornerstone of oncology management and are increasingly a development focus for the pharmaceutical industry. When 1+1 ≠ 2 In theory, combining two or more branded agents can lead to a price that exceeds SoC monotherapy.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Marketing Pharmaceutical manufacturing 105

Pharmaceutical Technology

MAY 23, 2023

With an increasing focus on ESG, Pharmaceutical companies are under pressure to incorporate sustainability with suppliers playing a crucial role in the process. Notably, the number of environmental sustainability-related patent applications in the pharmaceutical industry was 1,948 in Q1 2023, versus 2,528 in the prior quarter.

Pharmaceutical 52

Pharmaceutical Government Pharmaceutical manufacturing Manufacturing 52

Pharma Marketing Network

JANUARY 18, 2023

Bob is a life sciences and technology marketing leader with more than 25 years of experience working directly for pharmaceutical manufacturers (Merck, AstraZeneca, and Shire) and for technology companies that serve the industry (Appature, IQVIA, and Sparta). Bob is currently Sr.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Specialization Marketing Networking 52

Pharmaceutical Technology

MAY 9, 2023

With an increasing focus on ESG, Pharmaceutical companies are under pressure to incorporate corporate governance. Of the 50 leading companies in the pharmaceutical industry, GSK had the greatest increase in references for corporate governance in Q1 2023, compared with the previous quarter. Buy the report here.

Government 40

Government Pharmaceutical Pharmaceutical manufacturing Manufacturing 40

Pharmaceutical Technology

MAY 9, 2023

With an increasing focus on ESG, Pharmaceutical companies are under pressure to incorporate sustainability with suppliers playing a crucial role in the process. GlobalData identified 349 environmental sustainability-related sentences in the company's filings - 46% of all sentences - and an increase of 600% in Q1 2023 compared with Q4 2022.

Pharmaceutical 40

Pharmaceutical Pharmaceutical manufacturing Government Manufacturing 40

Impetus Digital

AUGUST 2, 2024

In 2022, the AI-fuelled pipeline reportedly expanded at an annual rate of almost 40%. Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology. Looking back at 2023 , AI for drug discovery saw both wins and losses.

Pharma 94

Pharma Manufacturing Medicine Marketing 94

European Pharmaceutical Review

JULY 21, 2023

A recent report from the US Food and Drug Administration (FDA) shows that while the number of new drug shortages has fallen significantly from a high of 250 in 2011 to 49 in 2022, there was an increase in new drug shortages year-on-year. What are the top three supply-related challenges facing pharmaceutical manufacturers?

Pharmaceutical 98

Pharmaceutical Food and Drug Administration Transportation Manufacturing 98

Medico Reach

FEBRUARY 8, 2023

The global pharmaceutical manufacturing market stood at USD 405.52 The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing. from 2022 to 2030, the pharma industry will reach USD 9,241.34 billion in 2022 and will expand at a CAGR of 10.3%

Pharma 52

Pharma Medicine Marketing Prospecting 52

Clarivate

MARCH 14, 2024

Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1] The food sector has already initiated the publication of preliminary regulations aimed at restricting PFAS in packaging. [3].

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

Pharmaceutical Technology

FEBRUARY 15, 2023

In an age of disruption, technology is key to enabling pharmaceutical manufacturers monitor, track and control shipments and their processes. Pharmaceutical firms are changing the way they do business; the future winners will be highly automated and digitalised. To learn more, download the paper below. [i]

Pharma 52

Pharma Pharmaceutical Manufacturing Medicine 52

Pharmaceutical Technology

DECEMBER 6, 2022

Despite the current emphasis on biologic medicines, small molecule drugs still dominate the pharmaceutical manufacturing world. Within the small molecule landscape, several trends are shaping the industry’s future, one of the most notable being the rise of high-potency active pharmaceutical ingredients (HPAPIs).

Manufacturing 52

Manufacturing Pharmaceutical Pharmaceutical manufacturing Safety 52